Net-Zero Pharma Supply Chain Market Size, Share, and Trends 2025 to 2034

Net zero pharma supply chain market overview collaboration on manufacture 2030, emissions data sharing, Scope 3 reduction and standardised LCA. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

Last Updated : July 2025  |  Report Code : 6437  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Net-Zero Pharma Supply Chain Market 

5.1. COVID-19 Landscape: Net-Zero Pharma Supply Chain Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Net-Zero Pharma Supply Chain Market, By Scope in Supply Chain

8.1. Net-Zero Pharma Supply Chain Market, by Scope in Supply Chain

8.1.1. Upstream Supply (Raw Material & API Sourcing)

8.1.1.1. Market Revenue and Forecast  

8.1.2. Manufacturing Operations

8.1.2.1. Market Revenue and Forecast  

8.1.3. Packaging

8.1.3.1. Market Revenue and Forecast  

8.1.4. Cold Chain & Logistics

8.1.4.1. Market Revenue and Forecast  

8.1.5. Warehousing & Distribution

8.1.5.1. Market Revenue and Forecast  

8.1.6. Reverse Logistics & Waste Management

8.1.6.1. Market Revenue and Forecast  

8.1.7. End-to-End Carbon Management Platforms

8.1.7.1. Market Revenue and Forecast  

Chapter 9. Global Net-Zero Pharma Supply Chain Market, By Component

9.1. Net-Zero Pharma Supply Chain Market, by Component

9.1.1. Solutions

9.1.1.1. Market Revenue and Forecast  

9.1.2. Services

9.1.2.1. Market Revenue and Forecast  

Chapter 10. Global Net-Zero Pharma Supply Chain Market, By Emission Scope Addressed

10.1. Net-Zero Pharma Supply Chain Market, by Emission Scope Addressed

10.1.1. Scope 1 (Direct Emissions: On-site)

10.1.1.1. Market Revenue and Forecast  

10.1.2. Scope 2 (Indirect Emissions: Purchased Energy)

10.1.2.1. Market Revenue and Forecast  

10.1.3. Scope 3 (Value Chain Emissions: Suppliers, Logistics, Use Phase)

10.1.3.1. Market Revenue and Forecast  

Chapter 11. Global Net-Zero Pharma Supply Chain Market, By Deployment Type

11.1. Net-Zero Pharma Supply Chain Market, by Deployment Type

11.1.1. On-Premise Solutions

11.1.1.1. Market Revenue and Forecast  

11.1.2. Cloud-Based Solutions

11.1.2.1. Market Revenue and Forecast  

11.1.3. Hybrid Deployment

11.1.3.1. Market Revenue and Forecast  

Chapter 12. Global Net-Zero Pharma Supply Chain Market, By End-User

12.1. Net-Zero Pharma Supply Chain Market, by End-User

12.1.1. Pharmaceutical Manufacturers

12.1.1.1. Market Revenue and Forecast  

12.1.2. Biotech Firms

12.1.2.1. Market Revenue and Forecast  

12.1.3. CMOs & CDMOs

12.1.3.1. Market Revenue and Forecast  

12.1.4. Distributors & Wholesalers

12.1.4.1. Market Revenue and Forecast  

12.1.5. Pharma Retail Chains & Pharmacies

12.1.5.1. Market Revenue and Forecast  

Chapter 13. Global Net-Zero Pharma Supply Chain Market, By Organization Size

13.1. Net-Zero Pharma Supply Chain Market, by Organization Size

13.1.1. Large Enterprises

13.1.1.1. Market Revenue and Forecast  

13.1.2. SMEs (including startups focusing on sustainability)

13.1.2.1. Market Revenue and Forecast  

Chapter 14. Global Net-Zero Pharma Supply Chain Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.1.2. Market Revenue and Forecast, by Component  

14.1.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.1.4. Market Revenue and Forecast, by Deployment Type  

14.1.5. Market Revenue and Forecast, by End-User  

14.1.6. Market Revenue and Forecast, by Organization Size  

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.1.7.2. Market Revenue and Forecast, by Component  

14.1.7.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.1.7.4. Market Revenue and Forecast, by Deployment Type  

14.1.8. Market Revenue and Forecast, by End-User  

14.1.8.1. Market Revenue and Forecast, by Organization Size   

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.1.9.2. Market Revenue and Forecast, by Component  

14.1.9.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.1.9.4. Market Revenue and Forecast, by Deployment Type  

14.1.10. Market Revenue and Forecast, by End-User  

14.2. Europe

14.2.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.2.2. Market Revenue and Forecast, by Component  

14.2.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.2.4. Market Revenue and Forecast, by Deployment Type   

14.2.5. Market Revenue and Forecast, by End-User  

14.2.6. Market Revenue and Forecast, by Organization Size  

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.2.8.2. Market Revenue and Forecast, by Component  

14.2.8.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.2.9. Market Revenue and Forecast, by Deployment Type   

14.2.10. Market Revenue and Forecast, by End-User  

14.2.10.1. Market Revenue and Forecast, by Organization Size   

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.2.11.2. Market Revenue and Forecast, by Component  

14.2.11.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.2.12. Market Revenue and Forecast, by Deployment Type  

14.2.13. Market Revenue and Forecast, by End-User  

14.2.14. Market Revenue and Forecast, by Organization Size  

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.2.15.2. Market Revenue and Forecast, by Component  

14.2.15.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.2.15.4. Market Revenue and Forecast, by Deployment Type  

14.2.16. Market Revenue and Forecast, by End-User  

14.2.16.1. Market Revenue and Forecast, by Organization Size  

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.2.17.2. Market Revenue and Forecast, by Component  

14.2.17.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.2.17.4. Market Revenue and Forecast, by Deployment Type  

14.2.18. Market Revenue and Forecast, by End-User  

14.2.18.1. Market Revenue and Forecast, by Organization Size  

14.3. APAC

14.3.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.3.2. Market Revenue and Forecast, by Component  

14.3.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.3.4. Market Revenue and Forecast, by Deployment Type  

14.3.5. Market Revenue and Forecast, by End-User  

14.3.6. Market Revenue and Forecast, by Organization Size  

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.3.7.2. Market Revenue and Forecast, by Component  

14.3.7.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.3.7.4. Market Revenue and Forecast, by Deployment Type  

14.3.8. Market Revenue and Forecast, by End-User  

14.3.9. Market Revenue and Forecast, by Organization Size  

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.3.10.2. Market Revenue and Forecast, by Component  

14.3.10.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.3.10.4. Market Revenue and Forecast, by Deployment Type  

14.3.11. Market Revenue and Forecast, by End-User  

14.3.11.1. Market Revenue and Forecast, by Organization Size  

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.3.12.2. Market Revenue and Forecast, by Component  

14.3.12.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.3.12.4. Market Revenue and Forecast, by Deployment Type  

14.3.12.5. Market Revenue and Forecast, by End-User  

14.3.12.6. Market Revenue and Forecast, by Organization Size  

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.3.13.2. Market Revenue and Forecast, by Component  

14.3.13.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.3.13.4. Market Revenue and Forecast, by Deployment Type  

14.3.13.5. Market Revenue and Forecast, by End-User  

14.3.13.6. Market Revenue and Forecast, by Organization Size  

14.4. MEA

14.4.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.4.2. Market Revenue and Forecast, by Component  

14.4.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.4.4. Market Revenue and Forecast, by Deployment Type  

14.4.5. Market Revenue and Forecast, by End-User  

14.4.6. Market Revenue and Forecast, by Organization Size  

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.4.7.2. Market Revenue and Forecast, by Component  

14.4.7.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.4.7.4. Market Revenue and Forecast, by Deployment Type  

14.4.8. Market Revenue and Forecast, by End-User  

14.4.9. Market Revenue and Forecast, by Organization Size  

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.4.10.2. Market Revenue and Forecast, by Component  

14.4.10.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.4.10.4. Market Revenue and Forecast, by Deployment Type  

14.4.11. Market Revenue and Forecast, by End-User  

14.4.12. Market Revenue and Forecast, by Organization Size  

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.4.13.2. Market Revenue and Forecast, by Component  

14.4.13.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.4.13.4. Market Revenue and Forecast, by Deployment Type  

14.4.13.5. Market Revenue and Forecast, by End-User  

14.4.13.6. Market Revenue and Forecast, by Organization Size  

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.4.14.2. Market Revenue and Forecast, by Component  

14.4.14.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.4.14.4. Market Revenue and Forecast, by Deployment Type  

14.4.14.5. Market Revenue and Forecast, by End-User  

14.4.14.6. Market Revenue and Forecast, by Organization Size  

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.5.2. Market Revenue and Forecast, by Component  

14.5.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.5.4. Market Revenue and Forecast, by Deployment Type  

14.5.5. Market Revenue and Forecast, by End-User  

14.5.6. Market Revenue and Forecast, by Organization Size  

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.5.7.2. Market Revenue and Forecast, by Component  

14.5.7.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.5.7.4. Market Revenue and Forecast, by Deployment Type  

14.5.8. Market Revenue and Forecast, by End-User  

14.5.8.1. Market Revenue and Forecast, by Organization Size  

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Scope in Supply Chain  

14.5.9.2. Market Revenue and Forecast, by Component  

14.5.9.3. Market Revenue and Forecast, by Emission Scope Addressed  

14.5.9.4. Market Revenue and Forecast, by Deployment Type  

14.5.9.5. Market Revenue and Forecast, by End-User  

14.5.9.6. Market Revenue and Forecast, by Organization Size  

Chapter 15. Company Profiles

15.1. Avery Dennison    

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. BCG (Net-Zero Practice for Life Sciences)

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Catalent

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. McKinsey & Company (QuantumBlack for decarbonization)

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Oracle (Supply Chain Management Cloud)

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. SAP SE

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Siemens AG

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Sphera Solutions

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Thermo Fisher Scientific

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. UPS Healthcare

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The major players in the net-zero pharma supply chain market include Amcor, Avery Dennison, BCG , Cardinal Health, Catalent, DHL Supply Chain, Enablon (Wolters Kluwer), IBM, IQVIA, McKinsey & Company, Microsoft, Oracle, SAP SE, Schneider Electric, Siemens AG, Sphera Solutions, Thermo Fisher Scientific, Tracelink, UPS Healthcare, and Vizient.

The driving factors of the net-zero pharma supply chain market are the increasing installation of on-site renewables such as solar microgrids and hydrogen fuel cells is driving self-sufficient pharmaceutical manufacturing.

Europe region will lead the global net-zero pharma supply chain market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client